Bot Detector
IJPC Seal
Download FREE Sample Issue or Article
LEARN MORE
Subscribe Today
A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of your subscribed issues, individual articles, and purchased archives.

Library Archives
Volume 26, 2022 Archive

Six issues from 2022 in one convenient archive.

  • Full-color, full-text PDF files of articles and formulations from the Journal.
  • Print or save articles for your research, marketing, and educational needs.
  • Log-in to your account for keyword or topical search and download.
  • Purchased items appear with download icon in contents and search results.

Only $30000


(Select Format)
Instant Online Access

This archive contains the following articles listed by volume, issue and page number:

Issues Included
Issue/Volume Title
January/February 2022
Vol. 26 No. 1
Volume 26, Number 1
March/April 2022
Vol. 26 No. 2
Volume 26, Number 2
May/June 2022
Vol. 26 No. 3
Volume 26, Number 3
July/August 2022
Vol. 26 No. 4
Volume 26, Number 4
September/October 2022
Vol. 26 No. 5
Volume 26, Number 5
November/December 2022
Vol. 26 No. 6
Volume 26, Number 6

Volume 26, 2022 Articles
Title/Author
(Click for Abstract / Details / Purchase)
Issue/​Page
View/Buy
PreScription: IJPC--Starting Year 26
Allen Loyd V Jr
Jan/Feb 2022
Pg. 4

Compounded Melatonin Cream for the Prevention and Treatment of Radiation Dermatitis: A Case Report
Garcia-Segura Laura Corral
, Garcia-Segura Javier Corral, Delgado Carlos Dorado, Maldonaldo Nuria Romero, Salgado Elena Cardero, Llorens Lucía Pérez
Jan/Feb 2022
Pg. 6-8

Pharmacy Student Satisfaction and Perceptions Following a Virtual Sterile Compounding Experience
Mohammad Insaf
, Lobkovich Alison, Nardolillo Joseph, Wilhelm Shelia
Jan/Feb 2022
Pg. 10-17

A Compendium of Compounding Agents and Formulations, Part 1: Melatonin
Riepl Mike
Jan/Feb 2022
Pg. 18-23

Editorial: Should All Pharmacists Compound?
Allen Loyd V Jr
Jan/Feb 2022
Pg. 24-28

Everything Old is New Again
Brunner Scott
Jan/Feb 2022
Pg. 30-32

Basics: Considerations and Background Information for Counseling Patients Using Compounded Suppositories
Allen Loyd V Jr
Jan/Feb 2022
Pg. 34-38

Sterile Basics: Compounding Sterile Preparations with Cyclodextrins
Allen Loyd V Jr
Jan/Feb 2022
Pg. 41-49

Calculations
Stockton Shelly J
Jan/Feb 2022
Pg. 50

Aluminum Chloride 6.25% in Anhydrous Alcohol
Allen Loyd V Jr
Jan/Feb 2022
Pg. 52

Ascorbic Acid 10% in Anhydrous PEG ointment
Allen Loyd V Jr
Jan/Feb 2022
Pg. 53

Deoxyarbutin 3% Anhydrous Emulsion
Allen Loyd V Jr
Jan/Feb 2022
Pg. 54

Diclofenac Sodium 1%-15% Topical Gel
Allen Loyd V Jr
Jan/Feb 2022
Pg. 55

Enalapril Maleate 1 mg-mL in Ora-Plus and Ora-Sweet Suspension
Allen Loyd V Jr
Jan/Feb 2022
Pg. 56

Mometasone Furoate 0.1% Lotion
Allen Loyd V Jr
Jan/Feb 2022
Pg. 57

Capsule Machine Validation
Al-Achi Antoine
, McGreggor Tysheon, Jaligama Shreelekha, Friday Kafi, Alyami Hussain
Jan/Feb 2022
Pg. 58-64

Physical Stability and Release Profile of Compounded Gabapentin Containing Pluronic Lecithin Organogel for Neuropathic Pain Management
Hong Eun Ji
, Sumanasekera Wasana, Le Uyen Minh
Jan/Feb 2022
Pg. 65-71

Evaluation of Closed-system Transfer Devices in Reducing Potential Risk for Surface Contamination Following Simulated Hazardous-drug Preparation and Compounding (Reprint)
Soefje Scott
, Rickabaugh Keith, Rajkumar Rahul, Wall Kathryn P
Jan/Feb 2022
Pg. 72-79

Investigation of the Effects of Excipients in the Compounding of Amlodipine Besylate Orally Disintegrating Tablets
Azmi Nurual Hanisah Saiful
, Ming Long Chiau, Uddin A.B.M. Helal, Sarker Zaidul Islam, Bin Liew Kai
Jan/Feb 2022
Pg. 80-87

PreScription: Comments on the FDA Guidance "Compounded Drug Products That Are Essentially Copies of a Commercially Available Drug Product Under Section 503A of the Federal Food, Drug, and Cosmetic Act: Guidance for Industry"
Allen Loyd V Jr
Mar/Apr 2022
Pg. 92

A Compendium of Compounding Agents and Formulations, Part 2: Metronidazole, Misoprostol, and Phenytoin
Riepl Mike
Mar/Apr 2022
Pg. 94-98

Allowing Compounding Pharmacies to Address Drug Shortages
Broughel James
Mar/Apr 2022
Pg. 100-109

The Potential Effects of a Compounded Methylcobalamin Nasal Spray on Short-term Memory Loss After Intracranial Hemorrhage: A Case Report
Good Lauren
, Lieu Yi, Banov Fabiana, Harger Beau, Banov Daniel
Mar/Apr 2022
Pg. 110-115

Quality Control: Photodocumentation in Pharmacy Compounding
Allen Loyd V Jr
Mar/Apr 2022
Pg. 116-117

Basics of Compounding: Compounding Nonsterile Preparations Using Cyclodextrins
Allen Loyd V Jr
Mar/Apr 2022
Pg. 118-126

Sterile Basics of Compounding: Methods of Sterilization and Depyrogenation
Allen Loyd V Jr
Mar/Apr 2022
Pg. 129-136

Calculations
Stockton Shelly J
Mar/Apr 2022
Pg. 138

Alprazolam 1 mg/mL in SyrSpend SF pH4 Oral Suspension
Allen Loyd V Jr
Mar/Apr 2022
Pg. 140

Codeine Phosphate 3 mg/mL in Ora-Sweet
Allen Loyd V Jr
Mar/Apr 2022
Pg. 141

Ketoconazole 2%, Terbenafine 1%, Acetic Acid 2%, and Urea 2% in Dimethyl Sulfoxide Nail Polish
Allen Loyd V Jr
Mar/Apr 2022
Pg. 142

Lorazepam 1 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
Mar/Apr 2022
Pg. 143

Mesalamine 100-mg/mL Suspension Enema
Allen Loyd V Jr
Mar/Apr 2022
Pg. 144

Naproxen 25 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
Mar/Apr 2022
Pg. 145

Phenobarbital 10 mg/mL in SyrSpend SF pH4, Cherry Flavored
Allen Loyd V Jr
Mar/Apr 2022
Pg. 146

Phenytoin 15 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
Mar/Apr 2022
Pg. 147

Propranolol 2 mg/mL and 5 mg/mL in Ora-Blend SF Suspension
Allen Loyd V Jr
Mar/Apr 2022
Pg. 148

Pyridoxine Hydrochloride 50 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
Mar/Apr 2022
Pg. 149

Stability Studies of Fludrocortisone Acetate Capsules and Fludrocortisone Acetate Titrated Powders (Powder Triturates)
Brandin Thibaut
, Wasilewski Maya, Panuccio Camille, Bouguergour Cyrielle, Primas Nicolas, Lamy Edouard, Jean Christophe, Bertault-Peres Pierre, Rathelot Pascal, Curti Christophe, Vanelle Patrice
Mar/Apr 2022
Pg. 150-154

Comparison of Solvent Casting and Spray Casting Method on Compounding of an Orally Disintegrating Film Containing Amlodipine Besylate
Ruslan Mohamad Fariz Haiqal
, Janakiraman Ashok Kumar, Ming Long Chiau, Uddin ABM Helal, Sarker Zaidul Islam, Bin Liew Kai
Mar/Apr 2022
Pg. 155-162

Molding as Innovative Technology for Personalized Tablet Production
Mady Omar Y
, Al-Shoubki Adam A, Hagag Youssef, Ibrahim Bakry, Donia Ahmed A
Mar/Apr 2022
Pg. 163-174

PreScription: Standing in the Gap
Allen Loyd V Jr
May/Jun 2022
Pg. 180

Art of Pharmacy v. State
Standridge Rob
May/Jun 2022
Pg. 182-186

A Compendium of Compounding Agents and Formulations, Part 3: Gentamicin Sulfate and Benzoyl Peroxide
Riepl Mike
May/Jun 2022
Pg. 189-193

A Procedure for Tablet Production by Using the 3D Molding Technology and Powder Micromeritics Properties
Mady Omar
May/Jun 2022
Pg. 195-200

Compounding for Investigational and Clinical Studies
Allen Loyd V Jr
May/Jun 2022
Pg. 201-209

Three Things You Need to Know Right Now
Brunner Scott
May/Jun 2022
Pg. 211-213

Basics of Compounding: Vehicle for Drug Administration via Enteral Feeding Tubes
Allen Loyd V Jr
May/Jun 2022
Pg. 214-217

Sterile Basics of Compounding: Particulates in Parenteral Preparations: Sources, Minimization, and Detection
Allen Loyd V Jr
May/Jun 2022
Pg. 219-228

Calculations
Stockton Shelly J
May/Jun 2022
Pg. 230

Alendronate Sodium 1% Topical Dental Gel
Allen Loyd V Jr
May/Jun 2022
Pg. 232

Azstarys in Ora-Blend Single Dose
Allen Loyd V Jr
May/Jun 2022
Pg. 233

Candesartan Cilexitil 1 mg/mL Syrup
Allen Loyd V Jr
May/Jun 2022
Pg. 234

Chloral Hydrate 70 mg/mL Syrup
Allen Loyd V Jr
May/Jun 2022
Pg. 235

Cinnarizine 1 mg/mL in Oral Medium-Chain Triglycerides Anhydrous Vehicle
Allen Loyd V Jr
May/Jun 2022
Pg. 236

Clobazam 1 mg/mL in Oral-Mix Suspension
Allen Loyd V Jr
May/Jun 2022
Pg. 237

Metronidazole 7.5 mg/mL Topical Oil-in-Water Microemulsion
Allen Loyd V Jr
May/Jun 2022
Pg. 238

Nitrazepam 1 mg/mL Oral Solution
Allen Loyd V Jr
May/Jun 2022
Pg. 239

Sirolimus 0.1% Ointment
Allen Loyd V Jr
May/Jun 2022
Pg. 240

Valganciclovir 20 mg/mL in Ora-Plus and Ora-Sweet Suspension
Allen Loyd V Jr
May/Jun 2022
Pg. 241

Finding the Right Balance: A Nationwide Study of Student Pharmacist Exposure to and Perceptions of Nonsterile Compounding
Fredrickson Mary E
, Belcher Faith G, Del Vecchio Kamryn N, Galleher Miranda N, Jugo Leila S, Gothard M David, Pallotta Raneem H, Pallotta Victor A Jr
May/Jun 2022
Pg. 242-247

Physical and Chemical Stability of Pharmaceutical Preparation of Bumetanide and Scopolamine
Catry Emilie
, Colsoul Marie-Louise, Closset Melanie, Hubert Justine, Soumoy Laura, Bihin Benoit, Thiry Emmanuell, Jamart Jacques, Hecq Jean-Daniel, Galanti Laurence
May/Jun 2022
Pg. 248-254

Application of Co-processed Excipient as a Novel Method to Compound Orally Disintegrating Tablets
Liew Kai Bin
, Hii Shou Hui, Chew Yik Ling, Ming Long Chiau, Uddin ABM Helal, Sarker Zaidul Islam
May/Jun 2022
Pg. 255-263

PreScription: Pharmacy and Drug Information
Allen Loyd V Jr
Jul/Aug 2022
Pg. 268

A Compendium of Compounding Agents and Formulations, Part 4: Nifedipine and Pentoxifylline
Riepl Mike
Jul/Aug 2022
Pg. 270-274

Compounding with Pracaxi Versus Copaiba Oil
Magutu Tom
Jul/Aug 2022
Pg. 277-281

Evaluation of the Physical-chemical Characteristics and Biopharmaceutical Performance of Dilu-Cap: A Complete Line of Excipients for Hard-shell Capsules
de Oliveira Ferreira Anderson
, Polonini Hudson
Jul/Aug 2022
Pg. 283-291

Compounding for Juvenile Idiopathic Arthritis and Other Pediatric Rheumatic Diseases
Harrington Amy
, Williams LaVonn
Jul/Aug 2022
Pg. 293-296

The Role of Compounding Pharmacists During Drug Shortages
Ofei Kelvin
Jul/Aug 2022
Pg. 298-301

Basics: Hollow-type Suppositories
Allen Loyd V Jr
Jul/Aug 2022
Pg. 302-307

Sterile Basics of Compounding: How to Implement a Robust Visual-inspection Program
Summers Amy
Jul/Aug 2022
Pg. 309-315

Calculations
Stockton Shelly J
Jul/Aug 2022
Pg. 316

Betamethasone Dipropionate 0.05% and Salicylic Acid 3% Lotion
Allen Loyd V Jr
Jul/Aug 2022
Pg. 318

Cetrimide Lotion
Allen Loyd V Jr
Jul/Aug 2022
Pg. 319

Dexamethasone 1 mg/mL in Oral Mix
Allen Loyd V Jr
Jul/Aug 2022
Pg. 320

Furosemide 5-mg/mL Oral Suspension
Allen Loyd V Jr
Jul/Aug 2022
Pg. 321-322

Hydralazine Hydrochloride 10 mg/mL Oral Liquid
Allen Loyd V Jr
Jul/Aug 2022
Pg. 323-324

Indomethacin 1% Topical Gel
Allen Loyd V Jr
Jul/Aug 2022
Pg. 325-326

Nystatin 250,000-unit Frozen Popsicles
Allen Loyd V Jr
Jul/Aug 2022
Pg. 327

Povidone Iodine 100-mg/mL Solution/Spray
Allen Loyd V Jr
Jul/Aug 2022
Pg. 328

Psoriasis Topical Ointment
Allen Loyd V Jr
Jul/Aug 2022
Pg. 329

Physicochemical and Microbiological Stability of Vancomycin 10-mg/mL Intravitreal Syringes
Bartoll Aaron Puplà
, Bellés Medall Maria Dolores, Peñarrocha Josep Edo, Escrig Laura Solaz, Clemente Ruben Eguren, Azuara Julia Bodega, Piqueres Raul Ferrando
Jul/Aug 2022
Pg. 330-335

Long-term Stability of Epitheliotropic Factors in Frozen Serum Eye Drops
Sahyoun Jean-Yves
, Cloutier Marc, Frenette Mathieu, Robert Marie-Claude
Jul/Aug 2022
Pg. 336-341

Physicochemical and Microbiological Stability of Amitriptyline Hydrochloride Oral Liquid Dosage Forms in PCCA Base, SuspendIt
Pramar Yashoda V
, Mandal Tarun K, Bostanian Levon A, Kader Cyndy, Morris Tommy C, Graves Richard A
Jul/Aug 2022
Pg. 342-351

PreScription: A New Dosage Form
Allen Loyd V Jr
Sep/Oct 2022
Pg. 356

Hazardous Drug Enteral Device: A Closed System Device for Crushing and Dispersing Hazardous Drug Tablets for Enteral Administration
Lopez C Vidal
, Rios GL Quito
Sep/Oct 2022
Pg. 358-362

A Compendium of Compounding Agents and Formulations, Part 5: Timolol and Beta-glucans
Riepl Mike
Sep/Oct 2022
Pg. 364-368

Recent Formulation Advances and Preparation of Orally Disintegrating Tablets
Ejeta Fikadu
Sep/Oct 2022
Pg. 370-377

Compounded Medications and Probiotics for Irritable Bowel Syndrome
Narváez Katherine Rivera
, Thompson Tara
Sep/Oct 2022
Pg. 378-384

Compounding with Biotechnology Products, Part 1: General Considerations
Allen Loyd V Jr
Sep/Oct 2022
Pg. 385-395

The FDA is in a Hole. It Should Stop Digging.
Brunner Scott
Sep/Oct 2022
Pg. 396-398

Basics of Compounding: Compounding with Microneedle Arrays, Part 1: Introduction and Overview
Allen Loyd V Jr
Sep/Oct 2022
Pg. 400-408

Sterile Basics of Compounding: Contamination Control Strategies, Part 1
Summers Amy
Sep/Oct 2022
Pg. 411-418

Calculations
Stockton Shelly J
Sep/Oct 2022
Pg. 420

Amphotericin B 3% Otic Gel
Allen Loyd V Jr
Sep/Oct 2022
Pg. 422

Ascorbic acid 5% Topical Microemulsion
Allen Loyd V Jr
Sep/Oct 2022
Pg. 423

Chlorhexidine Diacetate 2% Topical Gel
Allen Loyd V Jr
Sep/Oct 2022
Pg. 424

Clindamycin Hydrochloride 10-mg/mL Oral Suspension
Allen Loyd V Jr
Sep/Oct 2022
Pg. 425

Clotrimazole 10-mg Troches
Allen Loyd V Jr
Sep/Oct 2022
Pg. 426

Cysteamine Hydrochloride 100 mg/mL Oral Solution
Allen Loyd V Jr
Sep/Oct 2022
Pg. 427

Hydrogen Peroxide 1.5% with Sodium Fluoride 0.5-mg/mL Oral Rinse
Allen Loyd V Jr
Sep/Oct 2022
Pg. 428

Lansoprazole 3-mg/mL in Ora-Blend Suspension
Allen Loyd V Jr
Sep/Oct 2022
Pg. 429

Metronidazole 10%, Nifedipine 0.5%, Lidocaine 1.5%, and Diclofenac 3% Ointment
Allen Loyd V Jr
Sep/Oct 2022
Pg. 430

Methylcobalamin 2-mg/mL Nasal Spray
Allen Loyd V Jr
Sep/Oct 2022
Pg. 431

Effectiveness of a New Ultraviolet C Disinfection System to Inactivate Airborne Coronavirus in Different Environmental Conditions
Marianni Bruna
, Polonini Hudson
Sep/Oct 2022
Pg. 432-435

Effects of Calcium Polystyrene Sulfonate Formulation Change from Dry Syrup to Oral Solution in Patients with Chronic Kidney Disease
Kobayashi Shunsuke
, Ogawara Yuka, Imamura Yoshihiko, Kitaoka Akira, Yasu Takeo
Sep/Oct 2022
Pg. 436-439

PreScription: Compounded Drugs Often Become Manufactured Drugs
Allen Loyd V Jr
Nov/Dec 2022
Pg. 444

Compounding with Biotechnology Products, Part 2: Product-specific Considerations
Allen Loyd V Jr
Nov/Dec 2022
Pg. 446-466

Unlicensed Transdermal Medications in Feline Patients: Three Case Reports
Urwin Craig
, Jean Linda, Carvalho Maria, Robson-Laws Michael
Nov/Dec 2022
Pg. 468-472

Pharmacogenomics as a Competitive Strategy for Compounding Pharmacies
Maham Nicole Y
Nov/Dec 2022
Pg. 474-479

A Compendium of Compounding Agents and Formulations, Part 6: Additional Preparations for Refractory Dermal-wound Healing
Riepl Mike
Nov/Dec 2022
Pg. 480-488

Compounding with Microneedle Arrays, Part 2: Preparation and Administration Methods
Allen Loyd V Jr
Nov/Dec 2022
Pg. 490-495

Sterile Basics of Compounding: Contamination Control Strategies, Part 2
Summers Amy
Nov/Dec 2022
Pg. 497-504

Calculations
Stockton Shelly J
Nov/Dec 2022
Pg. 506

Bacitracin 0.01% and Phenol 0.1% in Cetaphil Lotion
Allen Loyd V Jr
Nov/Dec 2022
Pg. 508

Curcumin 2% Topical Gel
Allen Loyd V Jr
Nov/Dec 2022
Pg. 509

Diazoxide 10-mg/mL in Oral Mix SF
Allen Loyd V Jr
Nov/Dec 2022
Pg. 510

Enrofloxacin 11.35 mg/mL in Ora-Blend, Veterinary
Allen Loyd V Jr
Nov/Dec 2022
Pg. 511

Flucytosine 50 mg/mL in Oral-Sweet and Ora-Plus
Allen Loyd V Jr
Nov/Dec 2022
Pg. 512

Granisetron Hydrochloride 005 mg/mL in Ora-Sweet and Ora-Plus
Allen Loyd V Jr
Nov/Dec 2022
Pg. 513

Miller's Modified Mouthwash
Allen Loyd V Jr
Nov/Dec 2022
Pg. 514

Potassium Alum 1% Bladder Irrigation for Hemorrhagic Cystitis (Low-Medium Risk Compounding)
Allen Loyd V Jr
Nov/Dec 2022
Pg. 515

Formulation Development of Modafinil Sprinkle Dosage Form: Study on the Effect of Food on Dosage
Kumaravelrajan Rajagopal
, Karthik B, Venkatasan Suba
Nov/Dec 2022
Pg. 516-521

Intravenous Physical Compatibility of Heparin Sodium and Furosemide
Maktabi Briana
, Howard Mitchell S, Baki Gabriella, Churchwell Mariann D
Nov/Dec 2022
Pg. 522-526

Return to Top